Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Athersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way
Seeking Alpha
Sunday, January 5, 2014 - 12:15pm
tags:
Athersys, ischemic stroke, stroke, MultiStem, stem cells
Global reach of India drug producers grows
Financial Times, UK
Sunday, January 5, 2014 - 12:12pm
tags:
India
China Biotech In Review: China Starting Up Revamped IPO System
Seeking Alpha
Sunday, January 5, 2014 - 12:09pm
tags:
China, Stellar Biotechnologies, OBI Pharmaceuticals, Shenzhen Kangtai Biological, Zynex, Chugai, Pfizer
Bayer's hot-selling Eylea runs into a roadblock in its home market
Fierce Pharma
Saturday, January 4, 2014 - 4:32pm
tags:
Eylea, Bayer, Novartis, macular edema, Lucentis, Germany
NeXeption forms new company Alexar Therapeutics to develop novel LXR agonist portfolio for dermatologic indications
Pharmaceutical Business Review
Saturday, January 4, 2014 - 4:30pm
tags:
LXR agonists, NeXeption, Alexar Therapeutics
Horizon Pharma announces availability of Horizon-labeled Vimovo in United States
Pharmaceutical Business Review
Saturday, January 4, 2014 - 4:29pm
tags:
Vimovo, Horizon Pharma
Cocrystal Discovery merges with Washington biotechnology firm BioZone
NorthJersey.com
Saturday, January 4, 2014 - 4:22pm
tags:
BioZone, M&A, Cocrystal Discovery
Teva Pharma Detrol Launches Sales of Generic Detrol
Daily Finance
Saturday, January 4, 2014 - 4:20pm
tags:
generics, Teva, Detrol LA, overactive bladder
Three Medical Tech Names To Watch In Healthcare Space
Investors.com
Saturday, January 4, 2014 - 4:19pm
tags:
FONAR, devices, Cantel Medical, Cepheid
Capricor gets $12.5M upfront payment in Janssen development agreement
Yahoo/Fly on the Wall
Saturday, January 4, 2014 - 4:16pm
tags:
Capricor, Janssen, CAP-1002
Salix Pharma Completes Acquistion of Santarus
Yahoo/Zacks.com
Saturday, January 4, 2014 - 4:15pm
tags:
M&A, Salix, Santarus
Tetraphase Pharmaceuticals: A Small Cap With Big Potential
Seeking Alpha
Saturday, January 4, 2014 - 4:14pm
tags:
Tetraphase Pharmaceuticals, AstraZeneca, Cubist Pharmaceuticals, antiobiotics, Eravacycline, JNJ, Merck, Pfizer
Is Tamiflu Worth It? Britain Reconsiders a Best-Selling Flu Remedy
Bloomberg/Businessweek
Friday, January 3, 2014 - 4:06pm
tags:
Tamiflu, Roche, Great Britain
Dr Reddy's CEO for double-digit spending on R&D
Business Standard, India
Friday, January 3, 2014 - 4:05pm
tags:
India, R&D, Dr Reddy's
Boston Scientific doubled its market cap in 2013. What's in store this year?
Fierce Medical Devices
Friday, January 3, 2014 - 4:04pm
tags:
Boston Scientific, devices
AstraZeneca buys a CDK9 cancer drug portfolio
Fierce Biotech
Friday, January 3, 2014 - 1:36pm
tags:
AstraZeneca, CDK9, cancer, Probiodrug
Off-label Discussion at the CMS/FDA Summit
Coaltion for Healthcare Communication
Friday, January 3, 2014 - 1:04pm
tags:
off-label, FDA
3 Health Care Stocks Dragging The Sector Down
TheStreet.com
Friday, January 3, 2014 - 12:54pm
tags:
Illumina, Alexion, Regeneron
Buzz: If it's an Irish biopharma company, it's on analysts' M&A list
Fierce Biotech
Friday, January 3, 2014 - 12:52pm
tags:
Ireland, M&A, Elan, Warner Chilcott, Gentium, Jazz Pharmaceuticals
Amgen, UCB Drug Increases Bone Density in Phase 2 Trial
Drug Discovery and Development
Friday, January 3, 2014 - 12:50pm
tags:
UCB, Amgen, bone density, romosozumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.